Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer

References

• Yang, H. J., Xue, J. M., Li, J., Wan, L. H., & Zhu, Y. X. (2020). Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis. Molecular Genetics & Genomic Medicine, 8(6), e1200.
   PubMed Web of Science ®Google Scholar
• Balkwill, F. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Seminars in Cancer Biology, 14(3), 171–179.
   Google Scholar
• Hung, J. Y., Hsu, Y. L., Li, C. T., Ko, Y. C., Ni, W. C., Huang, M. S., & Kuo, P. L. (2009). 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells. Journal of Agricultural and Food Chemistry, 57(20), 9809–9816.
   PubMed Web of Science ®Google Scholar
• Adnan, M., Siddiqui, A. J., Hamadou, W. S., Snoussi, M., Badraoui, R., Ashraf, S. A., … Patel, M. (2021). Deciphering the molecular mechanism responsible for efficiently inhibiting metastasis of human non-small cell lung and colorectal cancer cells targeting the matrix metalloproteinases by Selaginella repanda. Plants, 10(5), 979.
   Google Scholar
• Al Moustafa, A. E., Yasmeen, A., & Achkhar, A. (2011). Src inhibitors are promising therapy molecules for human cervical carcinomas. Medical Hypotheses, 77(5), 812–814.
   PubMed Web of Science ®Google Scholar
• Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Finding the cancer-critical genes. In Molecular biology of the cell (4th ed.). Garland Science.
   Google Scholar
• Ali, B. H., Blunden, G., Tanira, M. O., & Nemmar, A. (2008). Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food and Chemical Toxicology, 46(2), 409–420.
   PubMed Web of Science ®Google Scholar
• Ali, S., & Coombes, R. C. (2002). Endocrine-responsive breast cancer and strategies for combating resistance. Nature Reviews Cancer, 2(2), 101–112.
   PubMed Web of Science ®Google Scholar
• Alquran, H., Alsalatie, M., Mustafa, W. A., Al Abdi, R., & Ismail, A. R. (2022). Cervical net: A novel cervical cancer classification using feature fusion. Bioengineering, 9, 578.
   PubMedGoogle Scholar
• An, T., Gong, Y., Li, X., Kong, L., Ma, P., Gong, L., Zhu, H., Yu, C., Liu, J., Zhou, H., Mao, B., & Li, Y. (2017). USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochemical Pharmacology, 131, 29–39. https://doi.org/10.1016/j.bcp.2017.02.011
   PubMed Web of Science ®Google Scholar
• Awadelkareem, A. M., Al-Shammari, E., Elkhalifa, A. O., Adnan, M., Siddiqui, A. J., Mahmood, D., … Ashraf, S. A. (2022). Anti-adhesion and antibiofilm activity of Eruca sativa miller extract targeting cell adhesion proteins of food-borne bacteria as a potential mechanism: Combined in vitro-in silico approach. Plants, 11(5), 610.
   Google Scholar
• Azmi, A. S. (2012). Network pharmacology for cancer drug discovery: Are we there yet? Future Medicinal Chemistry, 4(8), 939–941.
   PubMed Web of Science ®Google Scholar
• Baselga, J. (2002). Why the epidermal growth factor receptor? The rationale for cancer therapy. The Oncologist, 7(S4), 2–8.
   PubMedGoogle Scholar
• Berger, S. I., & Iyengar, R. (2009). Network analyses in systems pharmacology. Bioinformatics, 25(19), 2466–2472.
   PubMed Web of Science ®Google Scholar
• Bertelsen, B. I., Steine, S. J., Sandvei, R., Molven, A., & Laerum, O. D. (2006). Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation. International Journal of Cancer, 118(8), 1877–1883.
   PubMed Web of Science ®Google Scholar
• Bhalla, Y., Gupta, V. K., & Jaitak, V. (2013). Anticancer activity of essential oils: A review. Journal of the Science of Food and Agriculture, 93(15), 3643–3653.
   PubMed Web of Science ®Google Scholar
• Bhatt, M., Patel, M., Adnan, M., & Reddy, M. N. (2021). Anti-metastatic effects of lupeol via the inhibition of MAPK/ERK pathway in lung cancer. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 21(2), 201–206.
   PubMed Web of Science ®Google Scholar
• Bjorge, J. D., Pang, A., & Fujita, D. J. (2000). Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. The Journal of Biological Chemistry, 275(52), 41439–41446.
   PubMed Web of Science ®Google Scholar
• Burotto, M., Chiou, V. L., Lee, J. M., & Kohn, E. C. (2014). The MAPK pathway across different malignancies: a new perspective. Cancer, 120(22), 3446–3456.
   PubMed Web of Science ®Google Scholar
• Chandrashekar, D. S., Bashel, B., Balasubramanya, S. A. H., Creighton, C. J., Ponce-Rodriguez, I., Chakravarthi, B. V., & Varambally, S. (2017). UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia, 19(8), 649–658.
   PubMed Web of Science ®Google Scholar
• Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. The Lancet, 393(10167), 169–182.
   PubMed Web of Science ®Google Scholar
• Córdova-Alarcón, E., Centeno, F., Reyes-Esparza, J., García-Carrancá, A., & Garrido, E. (2005). Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. Archives of Medical Research, 36(4), 311–316.
   PubMed Web of Science ®Google Scholar
• Dehm, S. M., & Bonham, K. (2004). SRC gene expression in human cancer: The role of transcriptional activation. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 82(2), 263–274.
   PubMedGoogle Scholar
• DeVine, T., & Dai, M. S. (2013). Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy. Current Pharmaceutical Design, 19(18), 3248–3262.
   PubMed Web of Science ®Google Scholar
• Du, L., Rao, G., Wang, H., Li, B., Tian, W., Cui, J., He, L., Laffin, B., Tian, X., Hao, C. and Liu, H. (2013). CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal CancerPrPc + metastatic cancer stem cells. Cancer Research, 73(8), 2682–2694.
   PubMed Web of Science ®Google Scholar
• Dugasani, S., Pichika, M. R., Nadarajah, V. D., Balijepalli, M. K., Tandra, S., & Korlakunta, J. N. (2010). Comparative antioxidant and anti-inflammatory effects of [6]-gingerol,[8]-gingerol,[10]-gingerol and [6]-shogaol. Journal of Ethnopharmacology, 127(2), 515–520.
   PubMed Web of Science ®Google Scholar
• Elasbali, A. M., Al-Soud, W. A., Al-Oanzi, Z. H., Qanash, H., Alharbi, B., Binsaleh, N. K., … Adnan, M. (2022). Cytotoxic activity, cell cycle inhibition, and apoptosis-inducing potential of athyrium hohenackerianum (Lady Fern) with its phytochemical profiling. Evidence-Based Complementary and Alternative Medicine, 2022. https://doi.org/10.1155/2022/2055773
   Web of Science ®Google Scholar
• Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicologic Pathology, 35(4), 495–516.
   PubMed Web of Science ®Google Scholar
• Faried, L.S., Faried, A., Kanuma, T., Sano, T., Nakazato, T., Tamura, T., Kuwano, H. and Minegishi, T. (2006). Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncology Reports, 16(1), 57–63.
   PubMed Web of Science ®Google Scholar
• Formenti, S., Felix, J., Salonga, D., Danenberg, K., Pike, M. C., & Danenberg, P. (2000). Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. Clinical Cancer Research, 6(12), 4653–4657.
   PubMed Web of Science ®Google Scholar
• Friebel-Klingner, T.M., Luckett, R., Bazzett-Matabele, L., Ralefala, T.B., Monare, B., Nassali, M.N., Ramogola-Masire, D., Bvochora, M., Mitra, N., Wiebe, D. and Rebbeck, T.R. (2021). Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana. BMC Women’s Health, 21(1), 1–9.
   PubMed Web of Science ®Google Scholar
• Furumoto, H., & Irahara, M. (2002). Human papilloma virus (HPV) and cervical cancer. Journal of Medical Investigation, 49(3/4), 124–133.
   PubMedGoogle Scholar
• Ghaleh, H. E. G., Shahriary, A., Izadi, M., & Farzanehpour, M. (2022). Advances in early diagnosis of cervical cancer based on biosensors. Biotechnology and Bioengineering, 119(9), 2305–2312.
   PubMed Web of Science ®Google Scholar
• Guimarães, Y. M., Godoy, L. R., Longatto-Filho, A., & Reis, R. D. (2022). Management of early-stage cervical cancer: A literature review. Cancers, 14(3), 575.
   PubMed Web of Science ®Google Scholar
• Gupta, A.K., Lee, J.H., Wilke, W.W., Quon, H., Smith, G., Maity, A., Buatti, J.M. and Spitz, D.R. (2009). Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non–HPV-infected cell line and relationship to signaling through AKT. International Journal of Radiation Oncology* Biology* Physics, 74(3), 928–933.
   PubMed Web of Science ®Google Scholar
• Gupta, A., Shah, K., Oza, M. J., & Behl, T. (2019). Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 109, 484–492. https://doi.org/10.1016/j.biopha.2018.10.155
   PubMed Web of Science ®Google Scholar
• Ha, S. K., Moon, E., Ju, M. S., Kim, D. H., Ryu, J. H., Oh, M. S., & Kim, S. Y. (2012). 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology, 63(2), 211–223.
   PubMed Web of Science ®Google Scholar
• Hay, N., & Sonenberg, N. (2004). Upstream and downstream of mTOR. Genes & Development, 18(16), 1926–1945.
   PubMed Web of Science ®Google Scholar
• Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690.
   PubMed Web of Science ®Google Scholar
• Hoter, A., El-Sabban, M. E., & Naim, H. Y. (2018). The HSP90 family: Structure, regulation, function, and implications in health and disease. International Journal of Molecular Sciences, 19(9), 2560.
   PubMed Web of Science ®Google Scholar
• Huang, C., Liu, L.Y., Li, Z.F., Wang, P., Ni, L., Song, L.P., Xu, D.H. and Song, T.S. (2008). Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis. Cell Biology International, 32(9), 1081–1090.
   PubMed Web of Science ®Google Scholar
• Huang, Q., Matsuda, H., Sakai, K., Yamahara, J., & Tamai, Y. (1990). The effect of ginger on serotonin induced hypothermia and diarrhea. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan, 110(12), 936–942.
   PubMed Web of Science ®Google Scholar
• Jolad, S. D., Lantz, R. C., Chen, G. J., Bates, R. B., & Timmermann, B. N. (2005). Commercially processed dry ginger (Zingiber officinale): composition and effects on LPS-stimulated PGE2 production. Phytochemistry, 66(13), 1614–1635.
   PubMed Web of Science ®Google Scholar
• Jolad, S. D., Lantz, R. C., Solyom, A. M., Chen, G. J., Bates, R. B., & Timmermann, B. N. (2004). Fresh organically grown ginger (Zingiber officinale): Composition and effects on LPS-induced PGE2 production. Phytochemistry, 65(13), 1937–1954.
   PubMed Web of Science ®Google Scholar
• Kesic, V. (2006). Management of cervical cancer. European Journal of Surgical Oncology (EJSO), 32(8), 832–837.
   PubMed Web of Science ®Google Scholar
• Keysar, S.B., Astling, D.P., Anderson, R.T., Vogler, B.W., Bowles, D.W., Morton, J.J., Paylor, J.J., Glogowska, M.J., Le, P.N., Eagles-Soukup, J.R. and Kako, S.L. (2013). A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Molecular Oncology, 7(4), 776–790.
   PubMed Web of Science ®Google Scholar
• Kohrenhagen, N., Voelker, H. U., Schmidt, M., Kapp, M., Krockenberger, M., Frambach, T., … Kammerer, U. (2008). Expression of transketolase‐like 1 (TKTL1) and p‐Akt correlates with the progression of cervical neoplasia. Journal of Obstetrics and Gynaecology Research, 34(3), 293–300.
   PubMed Web of Science ®Google Scholar
• Kress, W. J., Prince, L. M., & Williams, K. J. (2002). The phylogeny and a new classification of the gingers (Zingiberaceae): Evidence from molecular data. American Journal of Botany, 89(10), 1682–1696.
   PubMed Web of Science ®Google Scholar
• Kulbe, H., Levinson, N. R., Balkwill, F., & Wilson, J. L. (2004). The chemokine network in cancer-much more than directing cell movement. The International Journal of Developmental Biology, 48(5-6), 489–496.
   PubMed Web of Science ®Google Scholar
• Kurmyshkina, O. V., Kovchur, P. I., & Volkova, T. O. (2015). Caspases as putative biomarkers of cervical cancer development. In Cell death-Autophagy, apoptosis and necrosis (pp. 267–297). INTECH.
   Google Scholar
• Lantz, R. C., Chen, G. J., Sarihan, M., Solyom, A. M., Jolad, S. D., & Timmermann, B. N. (2007). The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 14(2–3), 123–128.
   PubMed Web of Science ®Google Scholar
• Le Goff, P., Montano, M. M., Schodin, D. J., & Katzenellenbogen, B. S. (1994). Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. Journal of Biological Chemistry, 269(6), 4458–4466.
   PubMed Web of Science ®Google Scholar
• Lechner, J. F., & Stoner, G. D. (2019). Gingers and their purified components as cancer chemopreventative agents. Molecules, 24, 2859. https://doi.org/10.3390/molecules24162859
   PubMed Web of Science ®Google Scholar
• Lee, H.S., Lee, I.H., Kang, K., Park, S.I., Jung, M., Yang, S.G., Kwon, T.W. and Lee, D.Y. (2021). A comprehensive understanding of the anticancer mechanisms of FDY2004 against cervical cancer based on network pharmacology. Natural Product Communications, 16(3), 1934578X211004304.
   Web of Science ®Google Scholar
• Lee, H. S., Lee, I. H., Kang, K., Park, S. I., Moon, S. J., Lee, C. H., & Lee, D. Y. (2021). A network pharmacology study on the molecular mechanisms of FDY003 for breast cancer treatment. Evidence-Based Complementary and Alternative Medicine, 2021. https://doi.org/10.1155/2021/3919143
   Google Scholar
• Lee, E., & Surh, Y. J. (1998). Induction of apoptosis in HL-60 cells by pungent vanilloids,[6]-gingerol and [6]-paradol. Cancer Letters, 134(2), 163–168.
   PubMed Web of Science ®Google Scholar
• Lei, J., Ploner, A., Elfström, K. M., Wang, J., Roth, A., Fang, F., Sundström, K., Dillner, J., & Sparén, P. (2020). HPV vaccination and the risk of invasive cervical cancer. The New England Journal of Medicine, 383(14), 1340–1348.
   PubMed Web of Science ®Google Scholar
• Liang, T., He, Y., Chang, Y., & Liu, X. (2019). 6-shogaol a active component from ginger inhibits cell proliferation and induces apoptosis through inhibition of STAT-3 translocation in ovarian cancer cell lines (A2780). Biotechnology and Bioprocess Engineering, 24(3), 560–567.
   Web of Science ®Google Scholar
• Li, T. Y., & Chiang, B. H. (2017). 6-shogaol induces autophagic cell death then triggered apoptosis in colorectal adenocarcinoma HT-29 cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 93, 208–217. https://doi.org/10.1016/j.biopha.2017.06.038
   PubMed Web of Science ®Google Scholar
• Li, J., & Kurokawa, M. (2015). Regulation of MDM2 stability after DNA damage. Journal of Cellular Physiology, 230(10), 2318–2327.
   PubMed Web of Science ®Google Scholar
• Ling, L. R., & Wahab, A. (2005). Cytotoxic activity of selected Zingiberaceae. Malaysian Journal of Science, 24(1), 207–212.
   Google Scholar
• Li, D. J., Shi, J., Jin, J., Du, N. Y., & He, Y. T. (2021). Epidemiological trend of cervical cancer. Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology], 43(9), 912–916.
   PubMedGoogle Scholar
• Li, X., Tian, R., Gao, H., Yan, F., Ying, L., Yang, Y., Yang, P. and Gao, Y.E. (2018). Identification of significant gene signatures and prognostic biomarkers for patients with cervical cancer by integrated bioinformatic methods. Technology in Cancer Research & Treatment, 17, 1533033818767455.
   Web of Science ®Google Scholar
• Liu, Q., Peng, Y.-B., Zhou, P., Qi, L.-W., Zhang, M., Gao, N., Liu, E.-H., & Li, P. (2013). 6-Shogaol induces apoptosis in human leukemia cells through a process involving caspase-mediated cleavage of eIF2α. Molecular Cancer, 12(1), 135. https://doi.org/10.1186/1476-4598-12-135
   PubMedGoogle Scholar
• Li, L., Wang, L., You, Q. D., & Xu, X. L. (2019). Heat shock protein 90 inhibitors: An update on achievements, challenges, and future directions. Journal of Medicinal Chemistry, 63(5), 1798–1822.
   PubMed Web of Science ®Google Scholar
• Li, H., Wu, X., & Cheng, X. (2016). Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology, 27(4): e43.
   Web of Science ®Google Scholar
• Luo, T. T., Lu, Y., Yan, S. K., Xiao, X., Rong, X. L., & Guo, J. (2020). Network pharmacology in research of Chinese medicine formula: Methodology, application and prospective. Chinese Journal of Integrative Medicine, 26(1), 72–80.
   PubMed Web of Science ®Google Scholar
• Lv, J., & Li, L. (2019). Hub genes and key pathway identification in colorectal cancer based on bioinformatic analysis. BioMed Research International, 2019. https://doi.org/10.1155/2019/1545680.
   Google Scholar
• Lwin, W. W., Park, K., Wauson, M., Gao, Q., Finn, P. W., Perkins, D., & Khanna, A. (2012). Systems biology approach to transplant tolerance: Proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro. Journal of Surgical Research, 176(1), e41–e46.
   PubMed Web of Science ®Google Scholar
• Ma, Y. Y., Wei, S. J., Lin, Y. C., Lung, J. C., Chang, T. C., Whang-Peng, J., … Shen, C. Y. (2000). PIK3CA as an oncogene in cervical cancer. Oncogene, 19(23), 2739–2744.
   PubMed Web of Science ®Google Scholar
• Miller, P. C., Clarke, J., Koru-Sengul, T., Brinkman, J., & El-Ashry, D. (2015). A novel MAPK–microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast CancerhMAPK–miRNA signature and hormone resistance. Clinical Cancer Research, 21(2), 373–385.
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand‐receptor docking. Current Protocols in Bioinformatics, 24(1), 8–14.
   Google Scholar
• Niu, W. H., Wu, F., Cao, W. Y., Wu, Z. G., Chao, Y. C., Peng, F., & Liang, C. (2021). Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6. Bioscience Reports, 41(1), BSR20202583. https://doi.org/10.1042/BSR20202583.
   Web of Science ®Google Scholar
• Noor, F., Tahir Ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S., & Aljasir, M. A. (2022). Network pharmacology approach for medicinal plants: Review and assessment. Pharmaceuticals, 15(5), 572.
   Web of Science ®Google Scholar
• Obaidullah, A. J., Alanazi, M. M., Alsaif, N. A., Alanazi, A. S., Albassam, H., Az, A., … Tareq, A. M. (2022). Network pharmacology-and molecular docking-based identification of potential phytocompounds from Argyreia capitiformis in the treatment of inflammation. Evidence-Based Complementary and Alternative Medicine, 2022. https://doi.org/10.1155/2022/8037488
   Web of Science ®Google Scholar
• Olusola, P., Banerjee, H. N., Philley, J. V., & Dasgupta, S. (2019). Human papilloma virus-associated cervical cancer and health disparities. Cells, 8(6), 622.
   PubMed Web of Science ®Google Scholar
• Ordikhani, F., Erdem Arslan, M., Marcelo, R., Sahin, I., Grigsby, P., Schwarz, J. K., & Azab, A. K. (2016). Drug delivery approaches for the treatment of cervical cancer. Pharmaceutics, 8(3), 23.
   PubMed Web of Science ®Google Scholar
• Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S., & Surh, Y. J. (1998). Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Letters, 129(2), 139–144.
   PubMed Web of Science ®Google Scholar
• Patel, H., Polanco-Echeverry, G., Segditsas, S., Volikos, E., McCart, A., Lai, C., Guenther, T., Zaitoun, A., Sieber, O., Ilyas, M., Northover, J., & Silver, A. (2007). Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma. International Journal of Cancer, 121(12), 2668–2673.
   PubMed Web of Science ®Google Scholar
• Pearce, A., Haas, M., Viney, R., Pearson, S. A., Haywood, P., Brown, C., & Ward, R. (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One. 12(10), e0184360.
   PubMed Web of Science ®Google Scholar
• Pei, X. D., He, Z. L., Yao, H. L., Xiao, J. S., Li, L., Gu, J. Z., … Jiang, L. H. (2021). 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. European Journal of Nutrition, 60(5), 2781–2793.
   PubMed Web of Science ®Google Scholar
• Peter, K. V. (Ed.). (2006). Handbook of herbs and spices: volume 3. Woodhead Publishing.
   Google Scholar
• Poornima, P., Kumar, J. D., Zhao, Q., Blunder, M., & Efferth, T. (2016). Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature. Pharmacological Research, 111, 290–302.
   PubMed Web of Science ®Google Scholar
• Reddy, M. N., Adnan, M., Alreshidi, M. M., Saeed, M., & Patel, M. (2020). Evaluation of anticancer, antibacterial and antioxidant properties of a medicinally treasured fern tectaria coadunata with its phytoconstituents analysis by HR-LCMS. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 20(15), 1845–1856.
   PubMed Web of Science ®Google Scholar
• Rhode, J., Fogoros, S., Zick, S., Wahl, H., Griffith, K. A., Huang, J., & Liu, J. R. (2007). Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complementary and Alternative Medicine, 7(1), 1–9.
   PubMedGoogle Scholar
• Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Shukla, Y., & Singh, M. (2007). Cancer preventive properties of ginger: A brief review. Food and Chemical Toxicology, 45(5), 683–690.
   PubMed Web of Science ®Google Scholar
• Sirvent, A., Benistant, C., & Roche, S. (2012). Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer. American Journal of Cancer Research, 2(4), 357.
   PubMed Web of Science ®Google Scholar
• Soonthornthum, T., Arias-Pulido, H., Joste, N., Lomo, L., Muller, C., Rutledge, T., & Verschraegen, C. (2011). Epidermal growth factor receptor as a biomarker for cervical cancer. Annals of Oncology, 22(10), 2166–2178.
   PubMed Web of Science ®Google Scholar
• Stelzle, D., Tanaka, L. F., Lee, K. K., Khalil, A. I., Baussano, I., Shah, A. S., … Dalal, S. (2021). Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health, 9(2), e161–e169.
   PubMed Web of Science ®Google Scholar
• Studio, D. (2008). Discovery studio. Accelrys [2.1].
   Google Scholar
• Suekawa, M., Aburada, M., & Hosoya, E. (1986). Pharmacological studies on ginger. II. Pressor action of (6)-shogaol in anesthetized rats, or hindquarters, tail and mesenteric vascular beds of rats. Journal of Pharmacobio-Dynamics, 9(10), 842–852.
   PubMedGoogle Scholar
• Suekawa, M., Ishige, A., Yuasa, K., Sudo, K., Aburada, M., & Hosoya, E. (1984). Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents,(6)-gingerol and (6)-shogaol. Journal of Pharmacobio-Dynamics, 7(11), 836–848.
   PubMedGoogle Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
   PubMed Web of Science ®Google Scholar
• Surh, Y. J., Lee, E., & Lee, J. M. (1998). Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutation Research, 402(1–2), 259–267.
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., Kuhn, M., Bork, P., Jensen, L. J., & von Mering, C. (2015). STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Research, 43(Database issue), D447–D452. https://doi.org/10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Tan, B. S., Kang, O., Mai, C. W., Tiong, K. H., Khoo, A. S. B., Pichika, M. R., … Leong, C. O. (2013). 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). Cancer Letters, 336(1), 127–139.
   PubMed Web of Science ®Google Scholar
• Tornatta, J. M., Carpenter, J. S., Schilder, J., & Cardenes, H. R. (2009). Representations of vaginal symptoms in cervical cancer survivors. Cancer Nursing, 32(5), 378–384.
   PubMed Web of Science ®Google Scholar
• Tuorkey, M. J. (2015). Cancer therapy with phytochemicals: Present and future perspectives. Biomedical and Environmental Sciences : BES, 28(11), 808–819. https://doi.org/10.3967/bes2015.112
   PubMed Web of Science ®Google Scholar
• van Schalkwyk, S. L., Maree, J. E., & Dreyer Wright, S. C. (2008). Cervical cancer: The route from signs and symptoms to treatment in South Africa. Reproductive Health Matters, 16(32), 9–17.
   PubMed Web of Science ®Google Scholar
• Wang, W., Corrigan-Cummins, M., Hudson, J., Maric, I., Simakova, O., Neelapu, S. S., … Calvo, K. R. (2012). MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. haematologica, 97(4), 586.
   PubMed Web of Science ®Google Scholar
• Wu, B., & Xi, S. (2021). Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. BMC Cancer, 21(1), 1–15.
   PubMed Web of Science ®Google Scholar
• Yarley, O. P. N., Kojo, A. B., Zhou, C., Yu, X., Gideon, A., Kwadwo, H. H., & Richard, O. (2021). Reviews on mechanisms of in vitro antioxidant, antibacterial and anticancer activities of water-soluble plant polysaccharides. International Journal of Biological Macromolecules, 183, 2262–2271.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Wang, L., Xu, L., & Ying, P. (2022). A network pharmacology study on the cervix prescription for treatment of cervical cancer. Journal of Immunology Research, 2022. https://doi.org/10.1155/2022/8945591
   Web of Science ®Google Scholar
• Zhu, Y., Warin, R. F., Soroka, D. N., Chen, H., & Sang, S. (2013). Metabolites of ginger component [6]-shogaol remain bioactive in cancer cells and have low toxicity in normal cells: Chemical synthesis and biological evaluation. PLoS One, 8(1), e54677. https://doi.org/10.1371/journal.pone.0054677
   PubMed Web of Science ®Google Scholar
• Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., Xiao, Y., … Sun, S. C. (2014). USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nature Immunology, 15(6), 562–570.
   PubMed Web of Science ®Google Scholar